Connect with us

Hi, what are you looking for?

Economy

Identiv Partners with Tag-N-Trac to Market IoT Solutions for Cold Chain Tracking and Compliance

New condition monitoring IoT solution enhances supply chain visibility for pharmaceutical companies

Identiv, Inc., a global leader in RFID- and BLE-enabled Internet of Things (IoT) solutions, today announced a strategic business development and marketing partnership with Tag-N-Trac, a full stack IoT platform provider for real-time supply chain visibility and traceability.

This new partnership will initially focus on developing and commercializing specialized IoT solutions for cold chain tracking within the pharmaceutical industry supply chain.

The partnership combines Identiv’s advanced BLE smart labels with Tag-N-Trac’s RELATIVITY SaaS platform, an integrated IoT solution that delivers item-level visibility and actionable insights from origin to delivery. The RELATIVITY IoT platform brings together connectivity and data collection to deliver real-time visibility and traceability along with monitoring of ambient conditions such as item temperature and humidity, ensuring integrity and compliance for temperature sensitive products across the cold chain. The RELATIVITY platform is an industry-first single platform for “In warehouse” and “In transit” across globe visibility and traceability using purpose built smart labels and tags.

“As regulatory requirements and patient safety concerns grow, real-time data and visibility into the pharmaceutical cold chain have become critical,” said Kirsten Newquist, CEO at Identiv.

“Our strategic partnership with Tag-N-Trac supports pharmaceutical customers with smart, scalable IoT solutions that meet rigorous regulatory standards while optimizing operational efficiency.”

Identiv’s smart labels continuously capture raw environmental data throughout a product’s journey to delivery. Tag-N-Trac’s platform transforms this data into real-time analytics for monitoring location, condition, and chain-of-custody status, making the technology platform well suited for high-value products such as vaccines, biologics, and other temperature-sensitive medications.

“Cold chain visibility is one of the most complex and vital challenges in pharmaceutical distribution and logistics,” said Venu Gutlapalli, CEO of Tag-N-Trac. “Together with Identiv, we’re delivering a comprehensive digital solution that gives pharmaceutical companies the confidence and data intelligence to manage temperature-sensitive products safely, efficiently, and in full compliance.”

This strategic partnership reaffirms both companies’ commitment to building a smarter, more connected pharmaceutical supply chain through specialized IoT solutions.

The post Identiv Partners with Tag-N-Trac to Market IoT Solutions for Cold Chain Tracking and Compliance appeared first on IoT Business News.

You May Also Like

Latest News

Activists on Saturday demanded that the state of California pay millions of dollars to each Black resident in reparations as a way to make...

Latest News

President Biden is asking Congress to approve nearly $100 billion in emergency funding to aid recovery efforts for the recent deadly storms that ravaged...

Stock

One hallmark of secular bull markets is rotation. When leading stocks, sectors, and industry groups falter, there needs to be others that grab the...

Economy

Euro index and yen index in search of support levels The euro index was under strong pressure yesterday at the 1050.0 level. The value...



Disclaimer: Frequencytraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 Frequencytraders.com